BRISTOL-MYERS SQUIBB CO will deploy Anthropic's Claude AI model to 30,000 employees to accelerate drug discovery and delivery midday Wednesday. This move follows similar AI integrations by peers like ELI LILLY & CO to improve drug success rates. Investors are tracking whether AI can reduce the high costs and failure rates inherent in pharmaceutical research.

Breaking Down Data Silos